Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice...

由 Milane, Lara, Duan, Zhenfeng, Amiji, Mansoor
出版 2011

Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant Cancer

由 Milane, Lara, Duan, Zhenfeng, Amiji, Mansoor
出版 2011

Development of EGFR-Targeted Polymer Blend Nanocarriers for Combination Paclitaxel/Lonidamine Delivery to Treat Multi-Drug Resistance in Human Breast and Ovarian Tumor Cells

由 Milane, Lara, Duan, Zhenfeng, Amiji, Mansoor
出版 2010

NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance

由 Duan, Zhenfeng, Choy, Edwin, Hornicek, Francis J.
出版 2009

MicroRNA Involvement in Osteosarcoma

由 Kobayashi, Eisuke, Hornicek, Francis J., Duan, Zhenfeng
出版 2012

Role of MicroRNA-1 in Human Cancer and Its Therapeutic Potentials

由 Han, Chao, Yu, Zujiang, Duan, Zhenfeng, Kan, Quancheng
出版 2014

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma

由 Ren, Zhigang, Ma, Xiaochao, Duan, Zhenfeng, Chen, Xinhua
發表在 Anal Cell Pathol (Amst) (2020)

The roles and implications of exosomes in sarcoma

由 Min, Li, Shen, Jacson, Tu, Chongqi, Hornicek, Francis, Duan, Zhenfeng
發表在 Cancer Metastasis Rev (2016)

Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets

由 Min, Li, Garbutt, Cassandra, Tu, Chongqi, Hornicek, Francis, Duan, Zhenfeng
發表在 Int J Mol Sci (2017)

Application of metabolomics in sarcoma: from biomarkers to therapeutic targets

由 Min, Li, Choy, Edwin, Tu, Chongqi, Hornicek, Francis, Duan, Zhenfeng
發表在 Crit Rev Oncol Hematol (2017)

Therapeutic applications of histone deacetylase inhibitors in sarcoma

由 Tang, Fan, Choy, Edwin, Tu, Chongqi, Hornicek, Francis, Duan, Zhenfeng
發表在 Cancer Treat Rev (2017)

Novel strategies to prevent the development of multidrug resistance (MDR) in cancer

由 Wang, Jinglu, Seebacher, Nicole, Shi, Huirong, Kan, Quancheng, Duan, Zhenfeng
發表在 Oncotarget (2017)

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma

由 Ma, Hangzhan, Seebacher, Nicole A., Hornicek, Francis J., Duan, Zhenfeng
發表在 EBioMedicine (2018)

Targeting Protein Kinases to Reverse Multidrug Resistance in Sarcoma

由 Chen, Hua, Shen, Jacson, Choy, Edwin, Hornicek, Francis J., Duan, Zhenfeng
發表在 Cancer Treat Rev (2015)

The role of extracelluar matrix in osteosarcoma progression and metastasis

由 Cui, Juncheng, Dean, Dylan, Hornicek, Francis J., Chen, Zhiwei, Duan, Zhenfeng
發表在 J Exp Clin Cancer Res (2020)

The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer

由 Zhou, Yubing, Shen, Jacson K., Hornicek, Francis J., Kan, Quancheng, Duan, Zhenfeng
發表在 Oncotarget (2016)

Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma

由 Liu, Pei, Shen, Jacson K., Hornicek, Francis J., Liu, Fuyun, Duan, Zhenfeng
發表在 Sci Rep (2017)

Regulation of microRNAs function by circular RNAs in human cancer

由 Han, Chao, Seebacher, Nicole A., Hornicek, Francis J., Kan, Quancheng, Duan, Zhenfeng
發表在 Oncotarget (2017)

Noncoding RNA in drug resistant sarcoma

由 Li, Xiaoyang, Shen, Jacson K., Hornicek, Francis J., Xiao, Tao, Duan, Zhenfeng
發表在 Oncotarget (2017)

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer

由 Wang, Jinglu, Dean, Dylan C., Hornicek, Francis J., Shi, Huirong, Duan, Zhenfeng
發表在 FASEB J (2019)